ClariVest Asset Management’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,571
| Closed | -$1.45M | – | 762 |
|
|
2019
Q2 | $1.45M | Buy |
1,571
+907
| +137% | +$835K | 0.03% | 284 |
|
|
2019
Q1 | $1.06M | Sell |
664
-52
| -7% | -$82.9K | 0.02% | 391 |
|
|
2018
Q4 | $1.34M | Buy |
716
+277
| +63% | +$518K | 0.03% | 362 |
|
|
2018
Q3 | $1.04M | Sell |
439
-12
| -3% | -$28.3K | 0.02% | 422 |
|
|
2018
Q2 | $1.55M | Buy |
451
+82
| +22% | +$283K | 0.03% | 375 |
|
|
2018
Q1 | $1.05M | Buy |
369
+2
| +0.5% | +$5.68K | 0.02% | 426 |
|
|
2017
Q4 | $943K | Sell |
367
-23
| -6% | -$59.1K | 0.02% | 427 |
|
|
2017
Q3 | $1.11M | Hold |
390
| – | – | 0.03% | 335 |
|
|
2017
Q2 | $922K | Hold |
390
| – | – | 0.02% | 349 |
|
|
2017
Q1 | $983K | Hold |
390
| – | – | 0.02% | 340 |
|
|
2016
Q4 | $880K | Sell |
390
-1
| -0.3% | -$2.26K | 0.02% | 351 |
|
|
2016
Q3 | $980K | Hold |
391
| – | – | 0.03% | 310 |
|
|
2016
Q2 | $1.2M | Buy |
391
+119
| +44% | +$364K | 0.04% | 278 |
|
|
2016
Q1 | $863K | Buy |
272
+11
| +4% | +$34.9K | 0.03% | 302 |
|
|
2015
Q4 | $1.34M | Sell |
261
-6
| -2% | -$30.8K | 0.04% | 244 |
|
|
2015
Q3 | $851K | Sell |
267
-6
| -2% | -$19.1K | 0.03% | 287 |
|
|
2015
Q2 | $1.09M | Sell |
273
-1
| -0.4% | -$4K | 0.03% | 275 |
|
|
2015
Q1 | $1.09M | Buy |
274
+57
| +26% | +$227K | 0.03% | 280 |
|
|
2014
Q4 | $1.06M | Buy |
+217
| New | +$1.06M | 0.04% | 224 |
|